Myoepithelial and oral intracranial myxoid mesenchymal tumor-like neoplasms as diagnostic considerations of the ever-expanding extracranial myxocollagenous tumors harboring FET-CREB fusions
Journal
Pathology Research and Practice
Journal Volume
229
Pages
153700
Date Issued
2022
Author(s)
Lee P.-H.
Kao Y.-C.
Hsieh T.-H.
Liao J.-B.
Li C.-F.
Chang Y.-M.
Chang C.-D.
Huang S.-C.
Chen T.-J.
Liu T.-T.
Yu S.-C.
Huang H.-Y.
Abstract
Aims: Intracranial myxoid mesenchymal tumors (IMMTs) with fusions between EWSR1/FUS and CREB transcription factors have morphologic overlap with myxoid angiomatoid fibrous histiocytoma (mAFH) and myoepithelial tumor/carcinoma (MET/MEC). We aimed to study
Subjects
Angiomatoid fibrous histiocytoma; CREB; Extracranial; FET; Myoepithelial; Myxocollagenous
SDGs
Other Subjects
adult; aged; Article; cancer growth; cancer recurrence; clinical article; cytoplasm; EWSR1 ATF1 gene; EWSR1 CREB1 gene; EWSR1 CREM gene; female; FUS CREM gene; fusion gene; gene; gene fusion; histiocytoma; human; intracranial myxoid mesenchymal tumor; int
Publisher
Elsevier GmbH
Type
journal article